153 related articles for article (PubMed ID: 17673260)
21. The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain.
Liang YC; Huang CC; Hsu KS
Neuropharmacology; 2007 Jul; 53(1):169-77. PubMed ID: 17572451
[TBL] [Abstract][Full Text] [Related]
22. Scutellaria baicalensis extract decreases cisplatin-induced pica in rats.
Aung HH; Dey L; Mehendale S; Xie JT; Wu JA; Yuan CS
Cancer Chemother Pharmacol; 2003 Dec; 52(6):453-8. PubMed ID: 12942313
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain.
Ahmed MM; Rajpal S; Sweeney C; Gerovac TA; Allcock B; McChesney S; Patel AU; Tilghman JI; Miranpuri GS; Resnick DK
Spine J; 2010 Dec; 10(12):1049-54. PubMed ID: 20920894
[TBL] [Abstract][Full Text] [Related]
24. Time-course analysis of pica in rats using an automatic feeding monitoring system.
Yamamoto K; Asano K; Matsukawa N; Imaizumi M; Yamatodani A
J Pharmacol Toxicol Methods; 2011; 63(1):30-4. PubMed ID: 20451632
[TBL] [Abstract][Full Text] [Related]
25. The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms.
Potenzieri C; Harding-Rose C; Simone DA
Brain Res; 2008 Jun; 1215():69-75. PubMed ID: 18486111
[TBL] [Abstract][Full Text] [Related]
26. The anti-cancer drug-induced pica in rats is related to their clinical emetogenic potential.
Yamamoto K; Nakai M; Nohara K; Yamatodani A
Eur J Pharmacol; 2007 Jan; 554(1):34-9. PubMed ID: 17109847
[TBL] [Abstract][Full Text] [Related]
27. The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain.
Herzberg U; Eliav E; Bennett GJ; Kopin IJ
Neurosci Lett; 1997 Jan; 221(2-3):157-60. PubMed ID: 9121688
[TBL] [Abstract][Full Text] [Related]
28. The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.
Abalo R; Cabezos PA; Vera G; Fernández-Pujol R; Martín MI
Neurogastroenterol Motil; 2010 Jun; 22(6):694-e206. PubMed ID: 20132133
[TBL] [Abstract][Full Text] [Related]
29. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
[TBL] [Abstract][Full Text] [Related]
30. Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development.
De Vry J; Jentzsch KR; Kuhl E; Eckel G
Behav Pharmacol; 2004 Feb; 15(1):1-12. PubMed ID: 15075621
[TBL] [Abstract][Full Text] [Related]
31. Induction and antagonism of pica induced by teriparatide in rats.
Yamamoto K; Kato N; Isogai Y; Kuroda T; Ishida T; Yamatodani A
Eur J Pharmacol; 2015 Oct; 764():457-462. PubMed ID: 26189023
[TBL] [Abstract][Full Text] [Related]
32. Pronociceptive effects of spinal dynorphin promote cannabinoid-induced pain and antinociceptive tolerance.
Gardell LR; Burgess SE; Dogrul A; Ossipov MH; Malan TP; Lai J; Porreca F
Pain; 2002 Jul; 98(1-2):79-88. PubMed ID: 12098619
[TBL] [Abstract][Full Text] [Related]
33. Effects of prenatal exposure to the CB-1 receptor agonist WIN 55212-2 or CO on the GABAergic neuronal systems of rat cerebellar cortex.
Benagiano V; Lorusso L; Flace P; Girolamo F; Rizzi A; Sabatini R; Auteri P; Bosco L; Cagiano R; Ambrosi G
Neuroscience; 2007 Nov; 149(3):592-601. PubMed ID: 17916407
[TBL] [Abstract][Full Text] [Related]
34. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia.
Rawls SM; Cabassa J; Geller EB; Adler MW
J Pharmacol Exp Ther; 2002 Jun; 301(3):963-8. PubMed ID: 12023525
[TBL] [Abstract][Full Text] [Related]
35. N-methyl-D-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia.
Rawls SM; Cowan A; Tallarida RJ; Geller EB; Adler MW
J Pharmacol Exp Ther; 2002 Oct; 303(1):395-402. PubMed ID: 12235276
[TBL] [Abstract][Full Text] [Related]
36. Neuropharmacological mechanisms of emesis. II. Effects of antiemetic drugs on cisplatin-induced pica in rats.
Takeda N; Hasegawa S; Morita M; Horii A; Uno A; Yamatodani A; Matsunaga T
Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):647-52. PubMed ID: 9053584
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoid WIN-55,212-2 mesylate inhibits tumor necrosis factor-α-induced expression of nitric oxide synthase in dorsal root ganglion neurons.
Tan R; Cao L
Int J Mol Med; 2018 Aug; 42(2):919-925. PubMed ID: 29786105
[TBL] [Abstract][Full Text] [Related]
38. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
Rahn EJ; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
[TBL] [Abstract][Full Text] [Related]
39. Intra-accumbal NMDA but not AMPA/kainate receptor antagonist attenuates WIN55,212-2 cannabinoid receptor agonist-induced antinociception in the basolateral amygdala in a rat model of acute pain.
Ghalandari-Shamami M; Hassanpour-Ezatti M; Haghparast A
Pharmacol Biochem Behav; 2011 Dec; 100(2):213-9. PubMed ID: 21924283
[TBL] [Abstract][Full Text] [Related]
40. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
Fattore L; Cossu G; Martellotta CM; Fratta W
Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]